Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?
about
Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?Abnormal fatty acid metabolism in childhood spinal muscular atrophyPhase II open label study of valproic acid in spinal muscular atrophyConsensus Statement for Standard of Care in Spinal Muscular AtrophyImmune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy miceROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targetsVitamin D intake is inadequate in spinal muscular atrophy type I cohort: correlations with bone healthNutritional practices at a glance: spinal muscular atrophy type I nutrition survey findings.Glucose metabolism and pancreatic defects in spinal muscular atrophyObservational study of caloric and nutrient intake, bone density, and body composition in infants and children with spinal muscular atrophy type I.A plural role for lipids in motor neuron diseases: energy, signaling and structure.Anesthesia and spinal muscle atrophy.Spinal muscular atrophy: new findings for an old pathology.Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?Proximal spinal muscular atrophy: current orthopedic perspective.Motor neuron mitochondrial dysfunction in spinal muscular atrophyDefects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology.Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape.Stress-Induced Ketoacidosis in Spinal Muscular Atrophy: An Under-Recognized Complication.Alternative mRNA Splicing in the Pathogenesis of Obesity.Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice.Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy mice
P2860
Q26774987-F8E47FDE-B5E3-436D-97C0-AD6331FAB12DQ28138438-9EC03D81-30DF-42AA-838A-EA51C8D7D5BBQ28475498-D62735EA-774D-4970-A7E7-371C696DE56DQ29028573-500FDC67-8552-48E8-B0BE-FF399AADAF08Q33614675-A63C14A6-24F6-4430-B83F-45039B1A5E32Q34103656-B52B7301-82F0-42CD-9004-8A150EBB47B0Q34653462-FB62F6D6-3D90-4264-B4E3-3871CFAF726DQ35101826-DD837FC4-4FE9-44E1-9055-BA572257D7BBQ35101838-24EA4105-A645-4C13-96E8-D918DE5E6EE1Q36357056-AA3D0E69-E908-4AF4-9510-990139B42DA5Q37594297-42CA13E3-277A-41BE-85B7-15184618F7D6Q38100295-75D986BE-697F-47FF-B31E-CED11F9DEE69Q38113286-B5F9134A-7096-4C6E-A867-109B5936086DQ38123249-FBA2FE80-E9DC-4CC7-8F46-02EA4764D663Q38176600-2B5AE767-28E2-490D-BEA8-8EB1732C95C2Q39733042-2D18CC86-814F-4034-AADD-CF8B0A8889A0Q40435457-0EB1583D-290E-4EF9-B714-326DAC6F9F8DQ47700306-8180097A-C2A9-418A-BAD1-2B453EC5CCA7Q53733437-206CACB0-B623-4289-8A65-D9CEFF6F0F8FQ54971907-D02DB704-FDAC-4F4F-825D-EA357C91E124Q55369340-EBD209B9-2FA6-4A3B-9CAC-D9AA7FDC8303Q57463072-16195CDA-283F-4B29-8122-2867522D3F25
P2860
Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Fatty acid oxidation abnormali ...... rimary or secondary defect(s)?
@ast
Fatty acid oxidation abnormali ...... rimary or secondary defect(s)?
@en
Fatty acid oxidation abnormali ...... rimary or secondary defect(s)?
@nl
type
label
Fatty acid oxidation abnormali ...... rimary or secondary defect(s)?
@ast
Fatty acid oxidation abnormali ...... rimary or secondary defect(s)?
@en
Fatty acid oxidation abnormali ...... rimary or secondary defect(s)?
@nl
prefLabel
Fatty acid oxidation abnormali ...... rimary or secondary defect(s)?
@ast
Fatty acid oxidation abnormali ...... rimary or secondary defect(s)?
@en
Fatty acid oxidation abnormali ...... rimary or secondary defect(s)?
@nl
P2093
P1433
P1476
Fatty acid oxidation abnormali ...... rimary or secondary defect(s)?
@en
P2093
A E Sloane
D C Lehotay
D S Millington
E J Donner
R I Kelley
P356
10.1016/0887-8994(94)00100-G
P407
P577
1995-01-01T00:00:00Z